Pelagos Insurance Capital Limited Just Beat EPS By 19%: Here's What Analysts Think Will Happen Next
Pelagos Insurance Capital Limited PLGO | 0.00 |
Pelagos Insurance Capital Limited (NYSE:PLGO) investors will be delighted, with the company turning in some strong numbers with its latest results. Pelagos Insurance Capital beat earnings, with revenues hitting US$611m, ahead of expectations, and statutory earnings per share outperforming analyst reckonings by a solid 19%. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.
Following the latest results, Pelagos Insurance Capital's six analysts are now forecasting revenues of US$2.52b in 2026. This would be an okay 2.6% improvement in revenue compared to the last 12 months. Statutory earnings per share are expected to decline 13% to US$3.82 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$2.64b and earnings per share (EPS) of US$3.29 in 2026. Although the analysts have lowered their revenue forecasts, they've also made a solid gain to their earnings per share estimates, which implies there's been something of an uptick in sentiment following the latest results.
There's been no real change to the average price target of US$23.00, with the lower revenue and higher earnings forecasts not expected to meaningfully impact the company's valuation over a longer timeframe. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Pelagos Insurance Capital at US$28.00 per share, while the most bearish prices it at US$20.00. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Pelagos Insurance Capital shareholders.
Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. It's pretty clear that there is an expectation that Pelagos Insurance Capital's revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 3.5% growth on an annualised basis. This is compared to a historical growth rate of 15% over the past three years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 2.5% annually. So it's pretty clear that, while Pelagos Insurance Capital's revenue growth is expected to slow, it's still expected to grow faster than the industry itself.
The Bottom Line
The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Pelagos Insurance Capital following these results. Regrettably, they also downgraded their revenue estimates, but the latest forecasts still imply the business will grow faster than the wider industry. Even so, long term profitability is more important for the value creation process. The consensus price target held steady at US$23.00, with the latest estimates not enough to have an impact on their price targets.
Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Pelagos Insurance Capital going out to 2028, and you can see them free on our platform here.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
